Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study
- PMID: 7881926
- DOI: 10.1002/bjs.1800820137
Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study
Abstract
The trends in treatment and outcome of 13,560 patients with pancreatic cancer, and in incidence of the disease, in the West Midlands health region were determined between 1957 and 1986 using data from the West Midlands Region Cancer Registry. Patients were divided into those diagnosed in the first 20 years (1957-1976, n = 7888) and the most recent 10 years (1977-1986, n = 5672). The disease was more common in men and the incidence increased up to 1970 after which it levelled off. In the 1977-1986 period a lower proportion of patients had laparotomy alone (825 (14.5 per cent) versus 1552 (19.7 per cent)), a similar proportion had bypass surgery (2010 (35.4 per cent) versus 2760 (35.0 per cent)), while a greater proportion had supportive care (2710 (47.8 per cent) versus 3368 (42.7 per cent)) but the resection rates were the same (145 (2.6 per cent) versus 208 (2.6 per cent)). The 30-day mortality rates between the two periods improved for resection (40 (27.6 per cent) versus 94 (45.2 per cent)), bypass surgery (436 (21.7 percent) versus 691 (25.0 per cent)) and laparotomy (372 (45.1 per cent) versus 873 (56.3 per cent)). The 12-month survival rate for bypass did not significantly differ during the study (14.9 per cent versus 12.4 per cent) but there was a significant improvement in the 5-year survival for resection (9.7 per cent versus 2.6 per cent, P < 0.015). The resection rates were low and 30-day mortality rates for surgery were high compared with those of other published series.
Comment in
-
Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the west Midlands: an epidemiological study.Br J Surg. 1996 Jun;83(6):874. doi: 10.1002/bjs.1800830654. Br J Surg. 1996. PMID: 8696770 No abstract available.
Similar articles
-
Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer.Br J Surg. 2017 Oct;104(11):1568-1577. doi: 10.1002/bjs.10602. Epub 2017 Aug 22. Br J Surg. 2017. PMID: 28832964
-
Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.Br J Surg. 2004 May;91(5):586-94. doi: 10.1002/bjs.4484. Br J Surg. 2004. PMID: 15122610 Clinical Trial.
-
Prognosis following surgical bypass compared with laparotomy alone in unresectable pancreatic adenocarcinoma.Br J Surg. 2016 Aug;103(9):1200-8. doi: 10.1002/bjs.10190. Epub 2016 Jun 2. Br J Surg. 2016. PMID: 27250937
-
Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer.Br J Surg. 2018 Jul;105(8):946-958. doi: 10.1002/bjs.10870. Epub 2018 Apr 30. Br J Surg. 2018. PMID: 29708592 Free PMC article. Review.
-
[The results of treatment for pancreatic cancer--statistic change].Nihon Geka Gakkai Zasshi. 1997 Jul;98(7):588-91. Nihon Geka Gakkai Zasshi. 1997. PMID: 9276863 Review. Japanese.
Cited by
-
Developments in pancreatic cancer surgery.Updates Surg. 2024 Jan;76(1):17-22. doi: 10.1007/s13304-023-01692-4. Epub 2023 Nov 9. Updates Surg. 2024. PMID: 37943494 Review.
-
Photodynamic therapy for cancer of the pancreas.Gut. 2002 Apr;50(4):549-57. doi: 10.1136/gut.50.4.549. Gut. 2002. PMID: 11889078 Free PMC article. Clinical Trial.
-
Cost-utility estimation of surgical treatment of pancreatic carcinoma aimed at cure.World J Surg. 2011 Mar;35(3):662-70. doi: 10.1007/s00268-010-0883-8. World J Surg. 2011. PMID: 21132294
-
Perioperative management in distal pancreatectomy: results of a survey in 23 European participating centres of the DISPACT trial and a review of literature.Trials. 2009 Jul 26;10:58. doi: 10.1186/1745-6215-10-58. Trials. 2009. PMID: 19630998 Free PMC article. Review.
-
The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis.Int J Pancreatol. 1998 Apr;23(2):83-100. doi: 10.1385/IJGC:23:2:83. Int J Pancreatol. 1998. PMID: 9629506 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical